restructuring

Layoffs

Pharma

ADC plots 17% staff cuts amid Zynlonta safety concerns

After a recent safety scare in a confirmatory trial of Zynlonta, ADC Therapeutics is tightening its belt.

Fraiser Kansteiner Jun 24, 2026 10:19am

Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm

Takeda

Takeda's $1.3B savings drive to impact 4,500 roles in '26

May 13, 2026 11:41am

NVS

Novartis charts another 60 layoffs at US corporate outpost

May 4, 2026 11:09am

a lot of scissors

Large pharma companies reduced head counts by over 22K in 2025

Mar 23, 2026 4:25pm

hand over keys buy house gift takeover acquisition

Lonza shakes off capsule business in $3B deal with Lone Star

Mar 6, 2026 4:00pm